Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Maguire

Showing results (11-20 of 373) with videos related to

Pageof 38
Sort By:
JAMA Ophthalmology|February 2, 2023
Pentosan Polysulfate Maculopathy-We Need to Know MoreMaureen G Maguire
JAMA Ophthalmology|May 8, 2020
Steps Forward in Analyzing Optical Coherence Tomography in Age-Related Macular Degeneration-Capitalizing on the Power of Artificial IntelligenceMaureen G Maguire
JAMA Ophthalmology|June 1, 2018
Understanding Variation in Response to Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular DegenerationMaureen G Maguire
Annual Review of Vision Science|July 23, 2021
Best Practices for the Design of Clinical Trials Related to the Visual SystemMaureen G Maguire
Ophthalmology|February 22, 2017
ReplyMaureen G Maguire,
JAMA Ophthalmology|December 23, 2016
Further Scrutiny of Vision Outcomes When Aflibercept Is Used as Rescue Treatment for Eyes With Diabetic Macular Edema Treated With LaserMaureen G Maguire
Investigative Ophthalmology & Visual Science|January 2, 2007
Children unable to perform screening tests in vision in preschoolers study: proportion with ocular conditions and impact on measures of test accuracyMaureen G Maguire,
Retina (Philadelphia, Pa.)|January 19, 2021
Dose Response in Antivascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Is It Only the Number of Injections?Maureen G Maguire
LDI Issue Brief|July 5, 2012
Comparing treatments for age-related macular degeneration: safety, effectiveness and costMaureen G Maguire
Investigative Ophthalmology & Visual Science|June 13, 2020
Assessing Intereye Symmetry and Its Implications for Study DesignMaureen G Maguire
Pageof 38

Showing results (11-20 of 373) with videos related to

Sort By:
Pageof 38
JAMA Ophthalmology|February 2, 2023
Pentosan Polysulfate Maculopathy-We Need to Know MoreMaureen G Maguire
JAMA Ophthalmology|May 8, 2020
Steps Forward in Analyzing Optical Coherence Tomography in Age-Related Macular Degeneration-Capitalizing on the Power of Artificial IntelligenceMaureen G Maguire
JAMA Ophthalmology|June 1, 2018
Understanding Variation in Response to Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular DegenerationMaureen G Maguire
Annual Review of Vision Science|July 23, 2021
Best Practices for the Design of Clinical Trials Related to the Visual SystemMaureen G Maguire
Ophthalmology|February 22, 2017
ReplyMaureen G Maguire,
JAMA Ophthalmology|December 23, 2016
Further Scrutiny of Vision Outcomes When Aflibercept Is Used as Rescue Treatment for Eyes With Diabetic Macular Edema Treated With LaserMaureen G Maguire
Investigative Ophthalmology & Visual Science|January 2, 2007
Children unable to perform screening tests in vision in preschoolers study: proportion with ocular conditions and impact on measures of test accuracyMaureen G Maguire,
Retina (Philadelphia, Pa.)|January 19, 2021
Dose Response in Antivascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Is It Only the Number of Injections?Maureen G Maguire
LDI Issue Brief|July 5, 2012
Comparing treatments for age-related macular degeneration: safety, effectiveness and costMaureen G Maguire
Investigative Ophthalmology & Visual Science|June 13, 2020
Assessing Intereye Symmetry and Its Implications for Study DesignMaureen G Maguire
Pageof 38